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Abstract: Several countries with generalized, high-
prevalence HIV epidemics, mostly in sub-Saharan Africa,
have experienced rapid declines in transmission. These
HIV epidemics, often with rapid onsets, have generally
been attributed to a combination of factors related to
high-risk sexual behavior. The subsequent declines in
these countries began prior to widespread therapy or
implementation of any other major biomedical preven-
tion. This change has been construed as evidence of
behavior change, often on the basis of mathematical
models, but direct evidence for behavior changes that
would explain these declines is limited. Here, we look at
the structure of current models and argue that the
common ‘‘fixed risk per sexual contact’’ assumption favors
the conclusion of substantial behavior changes. We argue
that this assumption ignores reported non-linearities
between exposure and risk. Taking this into account, we
propose that some of the decline in HIV transmission may
be part of the natural dynamics of the epidemic, and that
several factors that have traditionally been ignored by
modelers for lack of precise quantitative estimates may
well hold the key to understanding epidemiologic trends.
Introduction
Since the discovery of the first HIV/AIDS case more than three
decades ago, enormous progress has been made in understanding,
treating, and preventing the infection. For example, there is now
solid evidence that antiretroviral therapy (ART) taken by either
HIV-infected or uninfected individuals can prevent HIV trans-
mission [1–4]. Nevertheless, the epidemic keeps surprising us. In
particular, it has been noted that in many countries, notably in
highly affected sub-Saharan Africa, but also in India, HIV
prevalence is dropping fast [5]. In Zimbabwe, once one of the
worst affected countries, HIV prevalence levels have halved over
the past 12 years, dropping from 30% in 1998 to 15% in 2011 [6].
However, Zimbabwe is certainly not the first country to
experience such an epidemiological change, as in east and central
Africa, declines have been observed as early as the mid-1990s
(Figure 1A) [7–9].
While these drops in HIV prevalence are dramatic, underlying
changes in HIV incidence must have occurred several years earlier
and more rapidly (Figure 1B). This is because with an average
survival time of approximately ten years (in the absence of
treatment), even a sudden complete interruption in transmission
would translate into a gradual decline in prevalence. In Nairobi,
changes in infection risk seemed to occur in high-risk populations
first, while HIV prevalence in the general population was still
stable or increasing. In 1986, over 80% of sex workers were
HIV-infected, but this declined to less than 50% after 1997. Also,
incidence dropped dramatically in these sex workers [10]. In these
women, the per–unprotected-sex-act rate of HIV acquisition fell
over 4-fold between 1985 and 2005, and in a recent analysis of
2008–2011, HIV incidence was 2.2% in over 1,500 person-years
of follow-up (McKinnon et al., submitted).
This rapid decline has occurred at a time when we still do not
fully understand why HIV struck sub-Saharan Africa so excep-
tionally hard in the first place. At its peak, HIV prevalence in
several countries in Africa exceeded more than 20% of the adult
population, although there was a lot of heterogeneity both within
and between countries [11]. The epidemic onset in sub-Saharan
Africa was also often extremely rapid, with estimated prevalence
doubling rates of as little as one year, implying that each HIV-
infected person annually infects, directly or indirectly, another
(susceptible) individual [12]. With transmissions apparently
occurring over the entire infected period [13], this would seem
to suggest high levels of the basic reproduction number R0 (i.e., the
average number of secondary cases generated by an infected
individual, over the duration of his infection, when all contacts are
uninfected). This, however, seems to conflict with what studies
have shown about HIV transmission (in)efficiency. For example,
some 50% of HIV-affected couples are still discordant when
discovered, and during follow-up the annual seroconversion rate of
the HIV-negative partner has ranged from 2% to 12% [14–16].
With an average—untreated—survival after HIV infection being
approximately ten years, this would seem to suggest that, in the
heterosexual population, R0 cannot be much larger than one. With
such a low R0, generalized heterosexual epidemics either cannot
occur or only spread slowly [17]. This is, in fact, also what
happened outside of sub-Saharan Africa.
This discrepancy between high-prevalence sub-Saharan Africa
countries and the rest of the world has sparked many theories and
debates about what made Africa ‘‘special.’’ Indeed, there is still no
full consensus about the reasons why various African countries
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Figure 1. Adult (15–49) HIV prevalence (A) and annual incidence (B) in Zimbabwe, Kenya, Malawi, and Mozambique, 1990–2009 [8].
doi:10.1371/journal.pcbi.1003459.g001
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experienced severe generalized HIV epidemics while most of the
rest of the world did not. Most of the hypotheses focus on high-risk
sexual behavior such as rapid partner change and low condom
use, aggravated by transmission co-factors, notably other sexually
transmitted infections that are spread by the same high-risk sexual
behavior. Undoubtedly, highly connected sexual networks gener-
ated by unprotected, often transactional, sex with many different,
frequently concurrent, partners are common in Africa [18–27].
This is also shown by the high levels of conventional, bacterial
sexually transmitted infections (STIs) as well as HSV-2 in sub-
Saharan Africa, infections that have been implicated as transmis-
sion co-factors, although their exact role is still moot [28–34].
These risk factors have been incorporated in many mathematical
models of the HIV epidemic, models that have also been used to
interpret the recent decline in HIV transmission. Several modeling
studies interpreted the fall in HIV transmission, therefore, as a
decline in the very factors that made sub-Saharan Africa special.
However, as throughout history epidemics have always come
and gone, even without interventions, we should consider the
possibility that the decline in HIV transmission may also have
‘‘natural’’ causes. Here we discuss findings, both epidemiological
and from the basic sciences, which are currently ignored in HIV
transmission models and suggest that some of the dramatic decline
in HIV incidence may be part of the natural dynamics of the HIV
epidemic and might have occurred even in the absence of any
major behavior change. To fully explore the impact of these
findings, they should be incorporated in future modeling studies.
Current HIV Models, Common Assumptions, and
Their Limitations
Mathematical modeling of infectious diseases is a highly
developed science or technology, and software to accelerate the
development and implementation of models is increasingly
available [35–39]. For modeling complex situations that are
difficult to capture in finite sets of (differential) equations,
individual- or ‘‘agent-’’ based micro-simulation, such as used in
STDSIM and SimulAIDS, is now well developed [40–42].
Advanced methods for fitting models to data and to incorporate
uncertainty into inference and predictions have been used [43,44].
From the very beginning of the HIV epidemic, mathematical
modelers, together with epidemiologists and statisticians, have
been heavily involved in shaping our understanding of the
infection and its transmission [45]. They have also been
instrumental in the interpretation of observed trends, in planning
of prevention strategies, in guiding data collection, and in
developing scenarios for the future course of the epidemic [46–48].
Most models, irrespective of their implementation and mathe-
matical detail, incorporate a constant per-sexual-contact transmis-
sion risk, which may depend on the phase of infection of infected
partners, and STI cofactor effects that increase this risk. Given
these parameter values, infection can spread through dynamic
networks modeled with variable complexity. This constant risk
assumption implies that ‘‘pre-emptive saturation’’ is the only
density-dependent mechanism at play [49]. That is, transmission
will continue to increase until so many sex partners of HIV-
infected individuals are already infected that (on average) each
HIV-positive individual only infects one still uninfected individual.
The latter condition defines endemic equilibrium, which will set in
and remain ‘‘forever’’ unless behavior change or interventions shift
this equilibrium to lower levels. Moreover, in homogeneous
populations this equilibrium will be reached after a continuously
increasing prevalence with perhaps a minor ‘‘overshoot,’’ as
mortality lags—by about a decade—behind incidence [50]. Thus,
when incidence declines, the common fixed risk per sexual contact
assumption implies the conclusion of substantial sexual behavior
changes.
As in various countries the decline in HIV transmission started
prior to the year 2000, major biomedical interventions such as
antiretroviral therapy (ART) or male circumcision campaigns
cannot explain the decline in HIV transmission. Most current
models thus necessarily interpret the epidemiological change as
evidence of (large) changes in sexual behavior or depletion (by
higher AIDS mortality rates) of the group with the highest rates of
partner change or as proof of success of behavioral interventions
[51–54]. Several modeling studies have indeed come to this
conclusion, although it is unclear whether direct empirical studies,
mostly self-reported and therefore potentially biased, support
commensurate declines in risk behavior [55–69]. While such
behavior changes undoubtedly contributed to the decline in
transmission [70], they may not be the only explanation. That
other factors may play a role is supported by the observation that
population behavior change appears to fail to explain the early,
rapid declines in risk per unprotected contact among Kenyan sex
workers [10].
Non-linearity of the Relationship between the
Number of HIV Exposures and Infection Risk
It is widely believed that HIV transmission is very inefficient.
On average, a very small proportion of sexual encounters between
infected and uninfected partners lead to transmission [71]. When
transmission does take place, infection is often the result of a clonal
expansion of a single founder virus, and the probability of any one
virion (virus particle) successfully infecting a person must be on the
order of one in a billion [72]. This is corroborated by SIV (monkey
HIV) infection experiments, which often show a single cluster of
infected cells in the female genital tract in the first few days of SIV
infection [73]. Special factors, such as an STI cofactor effect,
therefore have to be invoked to plausibly explain and model the
observed epidemics.
Potentially misleading, however, may be the concept of per-
contact transmission risk. Several observations disprove a constant
per-coitus risk of transmission [74,75]. Downs and Vincenzi,
among the first authors to study this, have shown the relationship
between the number of sexual contacts and risk of HIV
transmission to be highly non-linear. In their study involving
563 heterosexual partners of HIV-infected subjects, the risk of
transmission was 10% for those with less than ten unprotected
contacts and increased to only 23% after 2,000 unprotected
contacts [76,77]. Thus, the first few sexual exposures are clearly
more dangerous than subsequent ones. Sex worker contacts of
Thai military conscripts were also associated with high per-contact
risk, as were contacts among adult film actors [78–80]. Low-dose
mucosal SIV challenge experiments in non-human primates
suggest a similar phenomenon; while some monkeys become
infected quite rapidly, others require far more challenges, at times
with higher virus doses, to achieve infection [81]. It is unclear,
however, how to unambiguously interpret this non-linearity with
major implications for modeling and model predictions. Interest-
ingly, another transmission non-linearity exists in the relationship
between viral load and the risk of infection at each sexual contact.
Each 10log increase in plasma HIV-1 RNA increases the per-act
risk of transmission by 2.9-fold; that is, the transmission risk seems
to be approximately proportional to the square root of the viral
load [82]. A similar non-linear relationship appears to exist
between HIV-1 RNA in the genital tract and the risk of
transmission to an uninfected partner [83].
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Perhaps, if (cumulative) risk is determined by numbers of
virions to which a person is exposed, irrespective of the number
of coital acts, then the non-linearity between number of contacts
and transmission risk may well reflect the same biological
phenomenon as between per-coitus viral dose and transmission
risk.
Biological Mechanisms of the Non-linearity in HIV
Transmission
Below we present some mechanisms that may account for the
non-linearity in the relationship between exposure and transmis-
sion risk.
Susceptibility of the HIV-negative partner
As with everything biological, susceptibility to infection is likely
to vary both among and within individuals. Early in the HIV
epidemic, it was discovered that individuals homozygous for the
D32 mutation of the CCR5 gene were practically resistant to HIV
infection [84]. Other genetic factors also appear to play a role in
susceptibility and resistance, but much of the genetics and biology
of resistance have remained elusive, and behavior and acquired
factors may also be important [85–89]. This raises the issue of
whether the increased transmission during acute infection is totally
due to an increased infectivity of the infected partner. Acute
infection in the HIV-positive partner is often the first exposure of
the negative partner to HIV, and it seems logical that the most
susceptible individuals get infected first and fast.
In statistical terms, when such heterogeneity is taken into
account, the duration to infection (in terms of exposure) is a
mixture of exponential distributions, with characteristically
declining hazard rates; i.e., risk appears to decline with the total
number of previous exposures [90]. As people can seroconvert
only once, heterogeneity in susceptibility is notoriously hard to
measure directly, but studies are highly suggestive that it can be
substantial. Sex workers in Nairobi in the 1980s reached very high
(.80%) infection levels, but the risk of seroconversion was strongly
negatively associated with duration of exposure and there was even
evidence of a small, highly resistant subgroup [91]. In our most
recent analysis, this decrease in risk was 24% per year of exposure
(McKinnon et al., submitted). The same has been observed in
other sex worker cohorts [92]. Whether heterogeneity in
susceptibility between individuals offers a totally satisfactory
explanation of the rapid HIV epidemiological change is still
unclear. By itself, it seems to fail to satisfactorily explain the onset
of the epidemic. It may be of interest that for the same final size of
the epidemic, heterogeneity in susceptibility could give rise to
faster epidemic onset. Perhaps because of the difficulty of
obtaining empirical estimates of the level of heterogeneity in
susceptibility, this variable has usually been ignored in HIV
epidemic models. Yet, heterogeneity in susceptibility and resis-
tance can have a major effect on the course of the epidemic. In
fact, models that incorporate this heterogeneity predict that
prevalence peaks and then drops, as actually observed (Figure 2)
[50]. Heterogeneity in susceptibility in its most extreme form,
where only a subset of individuals are (highly) susceptible, and the
rest minimally susceptible, may also lead to a fragmentation of
sexual networks as all connections (edges) via non-susceptibles
(nodes) are effectively removed. Thus, sexual networks consisting
of loosely connected ‘‘cliques’’ would fragment into disjointed sub-
networks, with obvious implications for HIV spread. Heterogene-
ity in susceptibility over time, within individuals, almost certainly
also exists but, except in the context of STIs, has remained largely
elusive.
Immunity
Current mathematical models of HIV ignore the possibility of
naturally acquired immunity. There is evidence of (cellular and
other) immune responses to HIV among exposed but uninfected
individuals, some of which are associated with reduced infection
risk, but whether such responses are evidence of (long-term)
protective acquired and/or adaptive immunity is unclear [93–97].
The success of the RV144 vaccine trial in Thailand should also
alert us to the possible existence of forms of protective immunity to
HIV [98,99]. Immunity could develop, for example, after
exposure to defective virions, i.e., virus particles unable to establish
a reproductive infection. Given these data, the non-linearity of the
relationship between number of contacts and transmission risk
may also be due to such acquired immunity, including mucosal
immune mechanisms such as HIV target cell availability, for
example [100]. If so, this immunity perhaps may only offer
protection against one of several strains, or subtypes (clades) of the
virus, with implications for the risks of partner change [101].
Another form of immunity that may be relevant is alloimmu-
nity, i.e., immunity to (HLA) antigens expressed by sex partners.
Early studies demonstrated potent anti-HIV activity induced by
allo-immunization in humans [102]. There is evidence that
transmission often takes place by HIV hitching a ride in cells.
As such cells express HLA molecules of the host, alloimmune
responses may be protective [103]. Evidence, albeit somewhat
conflicting, for the importance of these responses comes from both
mother-to-child and sexual transmission studies [104–108].
With the high strain diversity of HIV and the extremely high
degree of polymorphism of HLA antigens, one would expect
regular partners of HIV-infected individuals to benefit much more
from these types of immunity than (say) sex workers whose
immune systems have to cope with widely divergent HIV strains
and HLA antigens and whose alloimmune responses may even be
compromised by their high levels of concurrency [109]. If the non-
linearity of risk is due to some form of specific immunity, then this
would imply much greater risks associated with multiple and/or
concurrent partnerships than if it were due to, for example, innate,
broadly protective, susceptibility factors. New HIV-positive
partners would entail a very high risk during the first couple of
contacts, whereas innate resistance or susceptibility would not
discriminate between contacts with the same and with different
HIV-infected partners.
Interestingly, with alloimmunity, the risk associated with acute
phase infection of a seroconverting regular partner would be much
lower than the risk associated with a new seroconverting partner,
as it (the alloimmunity) is acquired before HIV exposure. This
would not be the case with immunity against the virus itself. It
seems likely that this may affect the relative importance of
concurrent versus new partnerships. To our knowledge, no study
has explored the implications of these types of immunity for the
spread of HIV. Infections for which immunity is a density-
dependent mechanism, such as measles, are often characterized by
epidemiological patterns of (periodic) violent outbreaks, followed
by subsequent declines when high levels of immunity in the
population (herd immunity) form an impediment to ongoing
transmission. Therefore, the epidemiological implications of HIV
immunity merit further study.
Heterogeneity in infectiousness
As viral load varies among people, one can expect some
individuals to be greater shedders of infectious virions, and thereby
more infectious, than others. Early-stage, acute infection has
been associated with high viral loads and high infectiousness, and
this seems to be the preferred ‘‘consensus’’ interpretation of the
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non-linearity of the relationship between exposure and risk. This
acute infection period (first few months) has been estimated to be
up to 26 times as infectious as the subsequent stage of infection
[13,110]. Yet, paradoxically, the elevation in transmissibility
observed during acute infection appears to be greater than would
be expected based on viral load alone (although not all virions may
be equally infectious), and direct evidence implicating acute
infections only comes from a single study that ignored alternative
explanations and whose methodology has been questioned [111–
113]. Nevertheless, several mathematical models have incorporat-
ed this aspect of transmission and even made quite definitive
estimates about the role of acute infections in overall HIV
transmission [114]. Unfortunately, the methodology used for
estimating this increased transmissibility completely ignores factors
such as heterogeneity in susceptibility (see above). Proper
estimation of the risk associated with acute infection per se would
require a comparison between new, HIV-naı¨ve partners of HIV-
infected individuals in the acute and post-acute phase, which has
never been done. Other, less understood, sources of heterogeneity
in infectiousness also appear to exist. In a cross-sectional study
from South Africa, viral loads varied by a factor of more than
10,000, but the factors underlying this heterogeneity are not
completely clear [115]. Some factors have been recognized; for
example, HLA-B57 and HLA-B27 genotypes have been associated
with better viral control, and this leads one to expect that
individuals with these HLA types are, on average, less infectious
than others [116]. However, there is also within-person variation,
and individuals may temporarily shed more infectious virions than
usual [117]. Some anecdotal ‘‘superspreading’’ events suggest that
heterogeneity in infectiousness can be substantial. A Zairian man
in Belgium infected 11 out of 19 female sex partners, often after a
single sexual contact [118]. Another case infected at least 11 of his
many female sex partners [119]. It is unclear what this implies for
HIV transmission in general, or the difference between transmis-
sion in Africa and other parts of the world. Africa has higher rates
of tropical infections, including malaria, which may increase HIV
viral load and transmission [120,121]. Heterogeneity in infec-
tiousness, as with heterogeneity in susceptibility, would explain
why some exposed individuals seroconvert after a few sexual
contacts, while others never acquire infection.
Conclusions
We have identified several aspects of HIV transmission that may
provide additional, alternative reasons for the rise and fall of HIV
in high-prevalence countries in Africa. Current models may be
misleading because factors such as heterogeneity in susceptibility,
which may have substantially impacted the course of the HIV
epidemic, have been ignored due to a lack of precise quantitative
estimates. Key observations, such as non-linearity of the relation-
ship between the number sex contacts and HIV transmission and
the high risks associated with a seroconverting partner have
consistently been interpreted, perhaps misinterpreted, in only a
single way, while other explanations, with different epidemiolog-
ical impacts, have been discounted. Thus, when incidence
declines, the common assumption of fixed risk per sexual contact
Figure 2. The projected course of the HIV epidemic (prevalence) under simplified assumptions about heterogeneity in
susceptibility to HIV infection [50]. For comparison, the dashed curve shows the projected course in the absence of such heterogeneity, but with
similar final size of the epidemic.
doi:10.1371/journal.pcbi.1003459.g002
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favors the conclusion of substantial changes in average sexual
behavior.
What would our ideas imply for modeling? First, uncertainty in
model structure, more than uncertainty in parameter values,
dominates model uncertainty, and modelers should be aware of
qualitatively different interpretations of available data. Micro-
simulation can be used to effectively model complex, non-linear
processes, in contrast to most models consisting of sets of
differential equations. Modelers should explore alternative inter-
pretations of available data and, together with epidemiologists and
basic scientists, try to formulate empirical studies to discriminate
between these interpretations. Scientific journals and reviewers,
rather than encouraging conformity, should encourage and invite
debate and dissenting interpretations of epidemiological studies.
Understanding HIV’s rise and fall could offer important lessons as
this and future epidemics unravel.
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